✦ LIBER ✦

A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease

✍ Scribed by Roger J. Waltzman

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 58 KB
Volume: 100
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20116

No coin nor oath required. For personal study only.

✦ Synopsis

is a member of the speaker's bureaus at Ortho Biotech (Bridgewater, NJ) and Amgen Inc. (Thousand Oaks, CA).

📜 SIMILAR VOLUMES

A randomized, active-control, pilot tria

A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease

✍ John A. Glaspy; Jaswant Sinh Jadeja; Glen Justice; Alex Fleishman; Gregory Rossi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract ## BACKGROUND Anemia in patients receiving chemotherapy can be ameliorated with recombinant human erythropoietin (rHuEPO), which is administered one to three times per week. Darbepoetin α, a new erythropoietic agent, has longer serum residence time, allowing it to be administered less

A randomized controlled trial of darbepo

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies

✍ Paul J. Hesketh; Francis Arena; Dhimant Patel; Matt Austin; Paul D'Avirro; Grego 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

## Abstract ## BACKGROUND The effect of using fixed versus weight‐based doses for erythropoietic agents has not been reported previously. To investigate this issue, the authors conducted a randomized Phase II study of darbepoetin alfa administered as either a fixed dose or a weight‐based dose usin